Literature DB >> 19032226

Caveolin-1 expression is a distinct feature of chronic rejection-induced transplant capillaropathy.

I Yamamoto1, S Horita, T Takahashi, A Kobayashi, D Toki, K Tanabe, M Hattori, S Teraoka, K Aita, M Nagata, Y Yamaguchi.   

Abstract

Peritubular capillary basement membrane multilayering (PTCBMML) is a pathological landmark of chronic rejection-induced transplant capillaropathy (TC), but its cellular mechanisms are not fully understood. We observed de novo caveolae formation in endothelial cells in TC under electron microscopy. To examine the role of caveolae and their structural components in TC, biopsy samples from cases of chronic rejection were double-immunostained for Caveolin-1 (Cav-1) and Pathologische Anatomie Leiden-endothelium (PAL-E; a marker of peritubular capillary [PC]). Thirty-two cases of chronic rejection (group I) were compared with 18 cases of interstitial fibrosis and tubular atrophy with no evidence of any specific etiology (IF/TA; group II) and eight cases of peritubular capillaritis (group III). The Cav-1/PAL-E immunoreactivities in groups I-III (%Cav-1/PAL-E) were 41.8+/-23.1%, 8.1+/-7.3% (p < 0.01 vs. group I) and 12.7+/-7.4% (p < 0.01 vs. group I), respectively. Furthermore, multiple linear regression models demonstrated that %Cav-1/PAL-E was independently associated with the PTCBMML grade and reduced PC number. No correlation was observed between %Cav-1/PAL-E and PC C4d deposition in group I. We conclude that de novo caveolae formation in PC endothelia is involved in TC in chronic rejection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032226     DOI: 10.1111/j.1600-6143.2008.02421.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Authors:  Tatsuhiro Yaginuma; Izumi Yamamoto; Hiroyasu Yamamoto; Jun Mitome; Yudo Tanno; Keitaro Yokoyama; Takenori Hayashi; Tetsuya Kobayashi; Michiaki Watanabe; Yutaka Yamaguchi; Tatsuo Hosoya
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

Review 2.  Current pathological perspectives on chronic rejection in renal allografts.

Authors:  Shigeo Hara
Journal:  Clin Exp Nephrol       Date:  2016-11-16       Impact factor: 2.801

3.  Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.

Authors:  Sergi Clotet-Freixas; Caitriona M McEvoy; Ihor Batruch; Chiara Pastrello; Max Kotlyar; Julie Anh Dung Van; Madhurangi Arambewela; Alex Boshart; Sofia Farkona; Yun Niu; Yanhong Li; Olusegun Famure; Andrea Bozovic; Vathany Kulasingam; Peixuen Chen; S Joseph Kim; Emilie Chan; Sajad Moshkelgosha; Syed Ashiqur Rahman; Jishnu Das; Tereza Martinu; Stephen Juvet; Igor Jurisica; Andrzej Chruscinski; Rohan John; Ana Konvalinka
Journal:  J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 10.121

4.  Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

Authors:  T H Guan; G Chen; B Gao; M R Janssen; L Uttarwar; A J Ingram; J C Krepinsky
Journal:  Diabetologia       Date:  2013-06-21       Impact factor: 10.122

5.  Magnetic Resonance Elastography-derived Stiffness Predicts Renal Function Loss and Is Associated With Microvascular Inflammation in Kidney Transplant Recipients.

Authors:  Anwar S Shatil; Anish Kirpalani; Eyesha Younus; Pascal N Tyrrell; Adriana Krizova; Darren A Yuen
Journal:  Transplant Direct       Date:  2022-05-13

6.  Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes.

Authors:  B A Adam; R N Smith; I A Rosales; M Matsunami; B Afzali; T Oura; A B Cosimi; T Kawai; R B Colvin; M Mengel
Journal:  Am J Transplant       Date:  2017-05-24       Impact factor: 9.369

7.  Comprehensive investigation of the caveolin 2 gene: resequencing and association for kidney transplant outcomes.

Authors:  Jennifer A McCaughan; Seamus Duffy; Thomas O'Hagan; Aisling E Courtney; Richard Borrows; Peter J Conlon; Alexander P Maxwell; Amy Jayne McKnight
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.